Regulation of leukemic stem cells by immune mechanisms
A Lola and John Grace Distinguished Lecture in Cancer Research
Prof. Dr. med. Adrian Ochsenbein is Director and Chief Physician of Inselspital, University Hospital Bern, University Hospital for Medical Oncology, Bern, Swiitzerland, having held senior roles in oncology and research throughout his career in Switzerland and the USA. His research focus examines the interaction of immune cells and leukemia and cancer cells. The main research focus is to analyze so-called cancer/leukemia stem cells. These cells are the origin of the disease and are responsible for relapse after successful chemotherapy. The aim of his research is to develop improved immunotherapies for different types of cancer. The studies are performed in pre-clinical mouse models and using primary patient material and humanized mouse models. Therefore, studies generate broad understanding of translational research from animal studies to clinical application. Focus areas are : ImmunOncology, Lung & thoracic tumours, Neuroendocrine tumours and Neurooncology.
Prof. Dr. med. Adrian Ochsenbein is member of the following scientific committees :
SNSF Research Council SNSF, Leenaards Foundation Scientific Committee, Swiss Bridge Foundation, Werner and Hedy Berger Janser Foundation and is also board member of the folowing foundations : KFS (Krebsforschung Schweiz), Marlies Schwegler Stiftung and Stiftung für Klinische Krebsforschung Bern.
Prof. Dr. med. Adrian Ochsenbein is Director and Chief Physician of Inselspital, University Hospital Bern, University Hospital for Medical Oncology, Bern, Swiitzerland, having held senior roles in oncology and research throughout his career in Switzerland and the USA. His research focus examines the interaction of immune cells and leukemia and cancer cells. The main research focus is to analyze so-called cancer/leukemia stem cells. These cells are the origin of the disease and are responsible for relapse after successful chemotherapy. The aim of his research is to develop improved immunotherapies for different types of cancer. The studies are performed in pre-clinical mouse models and using primary patient material and humanized mouse models. Therefore, studies generate broad understanding of translational research from animal studies to clinical application. Focus areas are : ImmunOncology, Lung & thoracic tumours, Neuroendocrine tumours and Neurooncology.
Prof. Dr. med. Adrian Ochsenbein is member of the following scientific committees :
SNSF Research Council SNSF, Leenaards Foundation Scientific Committee, Swiss Bridge Foundation, Werner and Hedy Berger Janser Foundation and is also board member of the folowing foundations : KFS (Krebsforschung Schweiz), Marlies Schwegler Stiftung and Stiftung für Klinische Krebsforschung Bern.
Practical information
- Informed public
- Free
- This event is internal
Organizer
- Prof. Freddy Radtke
Contact
- Lisa Smith, ISREC Administrative Assistant